1. Abrams P., Cardoso L., Fall M. et al. The standardization of terminology of low urinary tract function: report from the standardization sub-committee of the ICS // Neurol. Urodyn. 2002. Vol. 21. P. 167-178.
2. Abrams P. The standardization of terminology of low urinary tract function: report from the standardization sub-committee of the ICS / P. Abrams, L. Cardoso, M. Fall // Neurol. Urodyn. 2002. Vol. 21. P. 167-178.
3. Klarskov P., Andersen J.T., Asmussen C.F. et al. Acute urinary retention in women: a prospective study of 18 consecutive cases. 1987. Vol. 21, N 1. P. 29.
4. Afshar K., Jafari S., Marks A.J. et al. Nonsteroidal anti-inflammatory drugs (NSAIDs) and non-opioids for acute renal colic // Cochrane database Syst. Rev. 2015. Vol. 6. P. CD006027. DOI: 10.1002/14651858. CD006027.pub2.
5. Ahlstrand C., Tiselius H.G. Urine composition and stone formation during treatment with acetazolamide // Scand. J. Urol. Nephrol. 1987. Vol. 21, N 3. P. 225-228.
6. Bandi G., Best S.L., Nakada S.Y. Current practice patterns in the management of upper urinary tract calculi in the north central United States // J. Endourol. 2008. Vol. 22, N 4. P. 631-636. DOI: 10.1089/end.2007.0186.
7. Boyce C.J., Pickhardt P.J., Lawrence E.M. et al. Prevalence of Urolithiasis in Asymptomatic Adults: Objective Determination Using Low Dose Noncontrast Computerized Tomography // J. Urol. 2010. Vol. 183, N 3. P. 1017-1021. DOI: 10.1016/j.juro.2009.11.047.
8. Brandt B., Ostri P., Lange P., Kvist Kristensen J. Painful caliceal calculi. The treatment of small nonobstructing caliceal calculi in patients with symptoms. // Scand. J. Urol. Nephrol. 1993. Vol. 27, N 1. P. 75-76.
9. Bultitude M., Rees J. Management of renal colic // BMJ. 2012. Vol. 345. P. e5499-e5499. DOI: 10.1136/bmj.e5499.
10. Burgher A., Beman M., Holtzman J.L., Monga M. Progression of Nephrolithiasis: Long-Term Outcomes with Observation of Asymptomatic Calculi // J. Endourol. 2004. Vol. 18, N 6. P. 534-539. DOI: 10.1089/end.2004.18.534.
11. Cabrera F., Preminger G.M., Lipkin M.E. As low as reasonably achievable: Methods for reducing radiation exposure during the management of renal and ureteral stones // Indian J. Urol. 2014. Vol. 30, N 1. P. 55-59. DOI: 10.4103/0970-1591.124208.
12. Cameron M.A., Pak C.Y.C. Approach to the Patient With the First Episode of Nephrolithiasis // Clin. Rev. Bone Miner. Metab. 2004. Vol. 2, N 3. P. 265-278. DOI: 10.1385/BMM:2:3:265.
13. Campschroer T., Zhu Y., Duijvesz D. et al. Alpha-blockers as medical expulsive therapy for ureteral stones // Cochrane database Syst. Rev. 2014. N 4. P. CD008509. DOI: 10.1002/14651858.CD008509.pub2.
14. Cardis E., Vrijheid M., Blettner M. et al. The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: Estimates of Radiation-Related Cancer Risks // Radiat. Res. 2007. Vol. 167, N 4. P. 396-416. DOI: 10.1667/RR0553.1.
15. Chua M., Morales M., Sapno L. et al. Use of computed tomography scout film and Hounsfield unit of computed tomography scan in predicting the radio-opacity of urinary calculi in plain kidney, ureter and bladder radiographs // Urol. Ann. 2014. Vol. 6, N 3. P. 218. DOI: 10.4103/0974-7796.134270.
16. Cicerello E., Merlo F., Gambaro G. et al. Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients // J. Urol. 1994. Vol. 151, N 1. P. 5-9.
17. Coe F.L. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder // Ann. Intern. Med. 1977. Vol. 87, N 4. P. 404-410.
18. Coll D.M., Varanelli M.J., Smith R.C. Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT // Am. J. Roentgenol. 2002. Vol. 178, N 1). P. 101-103. DOI: 10.2214/ajr.178.1.1780101.
19. Contemporary Urology. Urology Times 2005 Fact Book. Advanstar Medical Economics Healthcare Communications Secondary Research Services 2005.
20. Council N.R. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. Washington, DC: The National Academies Press, 2006. DOI: 10.17226/11340.
21. Curhan G.C., Willett W.C., Speizer F.E. et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women // Ann. Intern. Med. 1997. Vol. 126, N 7. P. 497-504.
22. Dalla Palma L., Stacul F., Bazzocchi M. et al. Ultrasonography and plain film versus intravenous urography in ureteric colic // Clin. Radiol. 1993. Vol. 47, N 5. P. 333-336.
23. Dropkin B.M., Moses R.A., Sharma D., Pais V.M. The Natural History of Nonobstructing Asymptomatic Renal Stones Managed with Active Surveillance // J. Urol. 2015. Vol. 193, N 4. P. 1265-1269. DOI: 10.1016/j.juro.2014.11.056.
24. Duquenne S., Hellel M., Godinas L., De Leval J. Spasmolytics indication in renal colic: a literature review // Rev. Med. Liege. 2009. Vol. 64, N 1. P. 45-48.
25. European Association of Urology Guidelines on Urological Infections. URL: www.uroweb.org.
26. Falagas M.E., Vouloumanou E.K., Togias A.G. et al. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials // J. Antimicrob. Chemother. 2010. Vol. 65, N 9. P. 1862-1877. DOI: 10.1093/jac/dkq237.
27. Ferrandino M.N., Bagrodia A., Pierre S.A. et al. Radiation exposure in the acute and short-term management of urolithiasis at 2 academic centers // J. Urol. 2009. Vol. 181, N 2. P. 668-672; discussion 673. DOI: 10.1016/j.juro.2008.10.012.
28. Fink H.A., Wilt T.J., Eidman K.E. et al. Medical management to prevent recurrent nephrolithiasis in adults: A systematic review for an American College of Physicians Clinical Guideline // Ann/ Intern. Med. 2013. Vol. 158, N 7. DOI: 10.7326/0003-4819-158-7-201304020-00005.
29. Frassetto L., Kohlstadt I. Treatment and prevention of kidney stones: An Update // Am. Fam. Physician. 2011. Vol. 84, N 11. P. 1234-1242. DOI: d10124 [pii].
30. Fulgham P., Assimos D., Pearle M., Preminger G. Clinical effectiveness protocols for imaging in the management of ureteral calculous disease: AUA technology assessment // J. Urol. Elsevier, 2013. Vol. 189, N 4. P. 1203-1213. DOI: 10.1016/j.juro.2012.10.031.
31. Gambaro G., Reis-Santos J.M., Rao N Nephrolithiasis: Why Doesn’t Our "learning" Progress? // Eur. Urol. 2004. Vol. 45, N 5. P. 547-556. DOI: 10.1016/j.eururo.2003.10.017.
32. Glowacki L.S., Beecroft M.L., Cook R.J. et al. The natural history of asymptomatic urolithiasis // J. Urol. 1992. Vol. 147, N 2. P. 319-321.
33. Goel M.C., Ahlawat R., Kumar M., Kapoor R. Chronic renal failure and nephrolithiasis in a solitary kidney: role of intervention // J. Urol. 1997. Vol. 157, N 5. P. 1574-1577.
34. Gokce M.I., Ozden E., Suer E. et al. Comparison of imaging modalities for detection of residual fragments and prediction of stone related events following percutaneous nephrolitotomy // Int. Braz. J. Urol. 2015. Vol. 41. P. 86-90. DOI: 10.1590/S1677-5538.IBJU.2015.01.12.
35. Hamm M., Knopfle E., Wartenberg S. et al. Low dose unenhanced helical computerized tomography for the evaluation of acute flank pain // J. Urol. 2002. Vol. 167, N 4. P. 1687-1691.
36. Hübner W., Porpaczy P. Treatment of caliceal calculi // Br. J. Urol. 1990. Vol. 66, N 1. P. 9-11.
37. Hübner W.A., Irby P., Stoller M.L. Natural history and current concepts for the treatment of small ureteral calculi // Eur. Urol. 1993. Vol. 24, N 2. P. 172-176.
38. ICRP 1991. 1990 Recommendations of the International Commission on Radiological Protection. // 1990 Recomm. Int. Comm. Radiol. Prot.
39. Jackson R.D., LaCroix A.Z., Gass M. et al. Calcium plus Vitamin D Supplementation and the Risk of Fractures // N. Engl. J. Med. 2006. Vol. 354, N 7. P. 669-683. DOI: 10.1056/NEJMoa055218.
40. Jendeberg J., Geijer H., Alshamari M. et al. Size matters: The width and location of a ureteral stone accurately predict the chance of spontaneous passage // Eur. Radiol. 2017. DOI: 10.1007/s00330-017-4852-6.
41. Johnston R., Lin A., Du J., Mark S. Comparison of kidney-ureter-bladder abdominal radiography and computed tomography scout films for identifying renal calculi // BJU Int. Wiley/Blackwell (10.1111). 2009. Vol. 104, N 5. P. 670-673. DOI: 10.1111/j.1464-410X.2009.08542.x.
42. Naber K.G., Алиджанов Ж.Ф. Существуют ли альтернативные методы антибактериальной терапии и профилактики неосложненных инфекций мочевыводящих путей? // Урология. 2014. № 6. C. 5-13.
43. Kanno T., Kubota M., Sakamoto H. et al. Determining the efficacy of ultrasonography for the detection of ureteral stone // Urology. 2014. Vol. 84, N 3. P. 533-537. DOI: 10.1016/j.urology.2014.04.047.
44. Keeley F.X., Tilling K., Elves A. et al. Preliminary results of a randomized controlled trial of prophylactic shock wave lithotripsy for small asymptomatic renal calyceal stones // BJU Int. 2001. Vol. 87, N 1. P. 1-8.
45. Kim B.S., Hwang I.K., Choi Y.W, Namkung S. et al. Low-dose and standard-dose unenhanced helical computed tomography for the assessment of acute renal colic: prospective comparative study // Acta Radiol. 2005. Vol. 46, N 7. P. 756-763.
46. Knoll T., Schubert A.B., Fahlenkamp D. et al. Urolithiasis through the ages: Data on more than 200,000 urinary stone analyses // J. Urol. 2011. Vol. 185, N 4. P. 1304-1311. DOI: 10.1016/j. juro.2010.11.073.
47. Kober A., Dobrovits M., Djavan B. et al. Local Active Warming: An Effective Treatment for Pain, Anxiety and Nausea Caused by Renal Colic // J. Urol. 2003. Vol. 170, N 3. P. 741-744. DOI: 10.1097/01. ju.0000080570.83834.ad.
48. Köves B., Cai T., Veeratterapillay R. et al. Benefits and Harms of Treatment of Asymptomatic Bacteriuria: A Systematic Review and Meta-analysis by the European Association of Urology Urological Infection Guidelines Panel // Eur. Urol. 2017, Jul 25. pii: S0302-2838(17)30602-4. DOI: 10.1016/j. eururo.2017.07.014.
49. Lee T.T., Elkoushy M.A., Andonian S. Are stone analysis results different with repeated sampling? // Can. Urol. Assoc. J. 2014. Vol. 8, N 5-6. P. 317. DOI: 10.5489/cuaj.1872.
50. Levine J.A., Neitlich J., Verga M. et al. Ureteral calculi in patients with flank pain: correlation of plain radiography with unenhanced helical CT // Radiology. 1997. Vol. 204, N 1. P. 27-31. DOI: 10.1148/ radiology.204.1.9205218.
51. Liston T.G., Montgomery B.S., Bultitude M.I., Tiptaft R.C. Extracorporeal shock wave lithotripsy with the Storz Modulith SL20: the first 500 patients // Br. J. Urol. 1992. Vol. 69, N 5. P. 465-469.
52. Madore F., Stampfer M.J., Rimm E.B., Curhan G.C. Nephrolithiasis and Risk of Hypertension // Am. J. Hypertens. Oxford University Press, 1998. Vol. 11, N 1. P. 46-53. DOI: 10.1016/S0895- 7061(97)00371-3.
53. McVary K / BPH: Epidemiology and Comorbidities // Am. J. Manag. Care. 2006. Vol. 12, N 5. P. S122.
54. Mermuys K., De Geeter F., Bacher K. et al. Digital tomosynthesis in the detection of urolithiasis: Diagnostic performance and dosimetry compared with digital radiography with MDCT as the reference standard // AJR. 2010. Vol. 195, N 1. P. 161-167. DOI: 10.2214/AJR.09.3075.
55. Montes Cardona C.E., García-Perdomo H.A. Efficacy of phosphodiesterase type 5 inhibitors for the treatment of distal ureteral calculi: A systematic review and meta-analysis // Investig. Clin. Urol. 2017. Vol. 58, N 2. P. 82. DOI: 10.4111/icu.2017.58.2.82.
56. Naber K.G., Schito G., Botto H. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy // Eur. Urol. 2008. Vol. 54, N 5. Р. 1164-1175.
57. Nakada S.Y., Hoff D.G., Attai S. Determination of stone composition by noncontrast spiral computed tomography in the clinical setting // Urology. 2000. Vol. 55, N 6. P. 816-819.
58. Fong Y.K., Milani S., Djavan B. Natural history and clinical predictors of clinical progression in benign prostatic hyperplasia. AU SO // Curr. Opin. Urol. 2005. Vol. 15, N 1. P. 35. Department of Urology, University of Vienna, Vienna, Austria.
59. Jacobsen S.J., Jacobson D.J., Girman C.J. et al. Natural history of prostatism: risk factors for acute urinary retention AU SO // J. Urol. 1997. Vol. 158, N 2. P. 481. Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA.
60. Pak C.Y.C., Peterson R, Poindexter J.R. Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis // J. Urol. Elsevier. 2001. Vol. 165, N 2. P. 378-381. DOI: 10.1097/00005392- 200102000-00006.
61. Pearle M.S., Goldfarb D.S., Assimos D.G. et al. Medical management of kidney stones: AUA guideline // J. Urol. Elsevier Ltd. 2014. Vol. 192, N 2. P. 316-324. DOI: 10.1016/j.juro.2014.05.006.
62. Pearle M.S., Roehrborn C.G., Pak C.Y.C. Meta-Analysis of Randomized Trials for Medical Prevention of Calcium Oxalate Nephrolithiasis // J. Endourol. 1999. Vol. 13, N 9. P. 679-685. DOI: 10.1089/ end.1999.13.679.
63. Phillips R., Hanchanale V.S., Myatt A. et al. Citrate salts for preventing and treating calcium containing kidney stones in adults // Cochrane Database of Systematic Reviews / Ed. Biyani C.S. Chichester, UK: John Wiley & Sons, Ltd. 2015. N 10. P. CD010057. DOI: 10.1002/14651858.CD010057.pub2.
64. Poletti P.-A., Platon A., Rutschmann O.T., et al. Low-dose versus standard-dose CT protocol in patients with clinically suspected renal colic // AJR. Am. J. Roentgenol. 2007. Vol. 188, N 4. P. 927-933. DOI: 10.2214/AJR.06.0793.
65. Pushkar D.Y., Bernikov A.N., Sadchenko A.V. Silodosin in the treatment of patients with benign prostatic hyperplasia-results of Russian multicenter observational study // Urologiia. 2015. Vol. N 5. P. 31-37.
66. Pushkar D., Vinarov A., Spivak L. et al. Efficacy and safety of Afalaza in men with symptomatic benign prostatic hyperplasia at risk of progression: a multicenter, double-blind, placebo-controlled, randomized clinical trial // Central Eur. J. Urol. 2018. Vol. 71. P. 427-435. DOI:10.5173/ceju.2018.1803.
67. Rassweiler J.J., Renner C., Chaussy C., Thüroff S. Treatment of renal stones by extracorporeal shockwave lithotripsy: an update // Eur. Urol. 2001. Vol. 39, N 2. P. 187-199. DOI: 52435.
68. Ripollés T., Agramunt M., Errando J. et al. Suspected ureteral colic: plain film and sonography vs unenhanced helical CT. A prospective study in 66 patients // Eur. Radiol. 2004. Vol. 14, N 1. P. 129-136. DOI: 10.1007/s00330-003-1924-6.
69. Rippel C.A., Nikkel L., Lin Y.K. et al. Residual fragments following ureteroscopic lithotripsy: incidence and predictors on postoperative computerized tomography // J. Urol. 2012. Vol. 188, N 6. P. 2246-2251. DOI: 10.1016/j.juro.2012.08.040.
70. Rule A.D., Lieske J.C., Li X. et al. The ROKS nomogram for predicting a second symptomatic stone episode // J. Am. Soc. Nephrol. American Society of Nephrology. 2014. Vol. 25, N 12. P. 2878-2886. DOI: 10.1681/ASN.2013091011.
71. Rule A.D., Roger V.L., Melton L.J. et al. Kidney stones associate with increased risk for myocardial infarction // J. Am. Soc. Nephrol. American Society of Nephrology. 2010. Vol. 21, N 10. P. 1641-1644. DOI: 10.1681/ASN.2010030253.
72. Sairam K. Should we SUSPEND MET? Not really // Cent. Eur. J. Urol. 2016. Vol. 69, N 2. P. 183. DOI: 10.5173/ceju.2016.864.
73. Scales C.D., Smith A.C., Hanley J.M., Saigal C.S. Prevalence of kidney stones in the United States // Eur. Urol. 2012. Vol. 62, N 1. P. 160-165. DOI: 10.1016/j.eururo.2012.03.052.
74. Selby M.G., Vrtiska T.J., Krambeck A.E. et al. Quantification of asymptomatic kidney stone burden by computed tomography for predicting future symptomatic stone events // Urology. NIH Public Access. 2015. Vol. 85, N 1. P. 45-50. DOI: 10.1016/j.urology.2014.08.031.
75. Sener N.C., Bas O., Sener E. et al. Asymptomatic Lower Pole Small Renal Stones: Shock Wave Lithotripsy, Flexible Ureteroscopy, or Observation? A Prospective Randomized Trial // Urology. 2015. Vol. 85, N 1. P. 33-37. DOI: 10.1016/j.urology.2014.08.023.
76. Skolarikos A., Laguna M.P., Alivizatos G. et al. The role for active monitoring in urinary stones: a systematic review // J. Endourol. 2010. Vol. 24, N 6. P. 923-930. DOI: 10.1089/end.2009. 0670.
77. Smith M.J. Placebo versus allopurinol for renal calculi // J. Urol. 1977. Vol. 117, N 6. P. 690-692.
78. Sodickson A., Baeyens P.F., Andriole K.P. et al. Recurrent C.T., Cumulative Radiation Exposure, and Associated Radiation-induced Cancer Risks from CT of Adults // Radiology. 2009. Vol. 251, N 1. P. 175-184. DOI: 10.1148/radiol.2511081296.
79. Tan Y.H., Wong M. How significant are clinically insignificant residual fragments following lithotripsy? // Curr. Opin. Urol. 2005. Vol. 15, N 2. P. 127-131.
80. Taylor E.N., Curhan G.C. Diet and fluid prescription in stone disease // Kidney Int. Elsevier / 2006. Vol. 70, N 5. P. 835-839. DOI: 10.1038/sj.ki.5001656.
81. Taylor E.N., Stampfer M.J., Curhan G.C. Obesity, Weight Gain, and the Risk of Kidney Stones // JAMA. 2005. Vol. 293, N 4. P. 455. DOI: 10.1001/jama.293.4.455.
82. Tchey D.-U., Ha Y.S., Kim W.T. et al. Expectant Management of Ureter Stones: Outcome and Clinical Factors of Spontaneous Passage in a Single Institution’s Experience // Korean J. Urol. 2011. Vol. 52, N 12. P. 847-851. DOI: 10.4111/kju.2011.52.12.847.
83. Ramsey S., Palmer M. The management of female urinary retention // Int. Urol. Nephrol. 2006. Vol. 38, N 3-4. P. 533.
84. Türk C., Knoll T., Seitz C. et al. Medical Expulsive Therapy for Ureterolithiasis: The EAU Recommenda- tions in 2016 // Eur. Urol. 2017. Vol. 71, N 4. P. 504-507. DOI: 10.1016/j.eururo.2016.07.024.
85. Türk C., Petřík A., Sarica K. et al. EAU Guidelines on Urolithiasis. 2014. DOI: 10.1159/000049803.
86. Türk C., Petřík A, Sarica K. et al. EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis // Eur. Urol. 2015. Vol. 69, N 3. P. 1-7. DOI: 10.1016/j.eururo.2015.07.040.
87. Ulusan S., Koc Z., Tokmak N. Accuracy of sonography for detecting renal stone: comparison with CT // J. Clin. Ultrasound. 2007. Vol. 35, N 5. P. 256-261. DOI: 10.1002/jcu.20347.
88. Viprakasit D.P., Sawyer M.D., Herrell S.D., Miller N.L. Limitations of Ultrasonography in the Evaluation of Urolithiasis: A Correlation With Computed Tomography // J. Endourol. 2012. Vol. 26, N 3. P. 209-213. DOI: 10.1089/end.2011.0177.
89. Wei J., Calhoun E., Jacobsen S. Urologic diseases in America project: benign prostatic hyperplasia // J. Urol. 2005. Vol. 173. P. 1256.
90. West B., Luke A., Durazo-Arvizu R.A. et al. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994 // Am. J. Kidney Dis. 2008. Vol. 51, N 5. P. 741-747. DOI: 10.1053/j.ajkd.2007.12.030.
91. Worcester E.M., Coe F.L. New insights into the pathogenesis of idiopathic hypercalciuria // Semin. Nephrol. 2008. Vol. 28, N 2. P. 120-132. DOI: 10.1016/j.semnephrol.2008.01.005.
92. Worster A.S., Bhanich Supapol W. Fluids and diuretics for acute ureteric colic // Cochrane database Syst. Rev. 2012. Vol. 2. P. CD004926. DOI: 10.1002/14651858.CD004926.pub3.
93. Yuruk E., Binbay M., Sari E. et al. A Prospective, Randomized Trial of Management for Asymptomatic Lower Pole Calculi // J. Urol. 2010. Vol. 183, N 4. P. 1424-1428. DOI: 10.1016/j.juro.2009.12.022.
94. Zhang W., Zhou T., Wu T. et al. Retrograde Intrarenal Surgery Versus Percutaneous Nephrolithotomy Versus Extracorporeal Shockwave Lithotripsy for Treatment of Lower Pole Renal Stones: A Meta- Analysis and Systematic Review // J. Endourol. 2015. Vol. 29. P. 745-759. DOI: 10.1089/end.2014.0799.
95. Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Федеральные клинические рекомендации. М., 2017.
96. Гаджиева З.К. Нарушения мочеиспускания / З.К. Гаджиева; под ред. Ю.Г. Аляева. М.: ГЭО- ТАР-Медиа, 2010. 180 с.
97. Зайцев А.В., Тупикина Н.В. Рецидивирующая инфекция мочевых путей - междисциплинарная проблема // Медицинский совет. 2014. № 19 (Урология). С. 36-44.
98. Интегративная урология: руководство для врачей / Под ред. П.В. Глыбочко и Ю.Г. Аляева. М.: Медфорум, 2014. 432 с.
99. Колонтарев К.Б., Зайцев А.В., Пушкарь Д.Ю. Сравнительный анализ антибактериальной терапии острого цистита // Урология. 2013. № 3. С. 112-122.
100. Корнеев И.А. Эпидемиология расстройств мочеиспускания у мужчин Российской Федерации / И.А. Корнеев, Т.А. Алексеева, М.И. Коган, Д.Ю. Пушкарь // Урология. 2016. № 2 (приложе- ние). C. 1-9.
101. Мазо Е.Б., Кривобородов Г.Г. Гиперактивный мочевой пузырь. М.: Вече, 2003. 160 с.
102. Оптимизация финансовых затрат при оказании медицинской помощи пациентам с острой задержкой мочеиспускания в стационаре / Д.Ю. Пушкарь, В.А. Малхасян, Л.А. Ходырева, А.В. Зайцев, Г.Р. Касян, О.А. Цыбуля. Обзор препаратов для лечения неосложненного цистита у женщин // Медицинский совет. 2010. № 7-8. С. 60-66.
103. Пушкарь Д.Ю. Гиперактивный мочевой пузырь у женщин / Д.Ю. Пушкарь // М.: МедПресс Информ, 2003. 160 с.
104. Пушкарь Д.Ю. Клинические рекомендации / Д.Ю. Пушкарь, В.В. Дьяков, К.Б. Колонтарев [и др.]; под ред. акад. РАМН Н.А. Лопаткина. Урология. 2-е изд., перераб. М.: ГЭОТАР-Медиа, 2013. 416 с.
105. Пушкарь Д.Ю. Российские клинические рекомендации с современными данными ведущих российских специалистов. Симптомы нижних мочевыводящих путей и доброкачественная гиперплазия предстательной железы / Д.Ю. Пушкарь, П.И. Раснер, Р.Р. Харчилава // Уроло- гия. 2016. № 2 (приложение). C. 4-19.
106. Пушкарь Д.Ю. Урология. Российские клинические рекомендации / Д.Ю. Пушкарь, Ю.Г. Аляев, П.В. Глыбочко. М.: ГЭОТАР-Медиа, 2014. 192 c.
107. Пушкарь Д.Ю. Функциональная урология и уродинамика / Д.Ю. Пушкарь, Г.Р. Касян // М: ГЭОТАР-Медиа, 2013. 376 с.
108. Пушкарь Д.Ю., Раснер П.И., Котенко Д.В. и др. Особенности симптомов нижних мочевыводя- щих путей у мужчин Московского региона. Результаты эпидемиологического исследования // Урология. 2018. № 3. С. 20-28
109. Раснер П.И. Симптомы нижних мочевых путей: медикаментозное лечение симптомов фазы накопления (клиническая лекция) / П.И. Раснер, Д.Ю. Пушкарь // Consilium Medicum. 2016.№ 7(18). C. 30-36.
110. Урология. Клинические рекомендации / Под ред. Ю.Г. Аляева, П.В. Глыбочко, Д.Ю. Пушкаря. М.: ГЭОТАР-Медиа, 2016. 480 с.